IMPROVED ACCESS TO TECHNOLOGY NEEDED FOR PEOPLE WITH TYPE 2 DIABETES NEEDING INSULIN National Diabetes Services Scheme (NDSS) disparity in subsidised access to CGM systems
Australian Health Journal segment
Filmed in Canberra | March 2025
With
Susan Davidson, CEO
Australian Diabetes Educators Association
Sahar Awais,
NSW Registered Nurse
Susan Davidson is the CEO of the Australian Diabetes Educators Association (ADEA), the leading body for diabetes education in Australia. ADEA plays a crucial role in accrediting credentialed diabetes educators and providing essential training for all health professionals, as roughly 25% of individuals seeking healthcare are affected by diabetes.
In Australia, around 1.5 million people are diagnosed with diabetes, with an additional estimated 500,000 undiagnosed cases of Type 2 diabetes. Among those diagnosed, approximately 140,000 have Type 1 diabetes, while 1.3 million live with Type 2 diabetes, and about 65% of these individuals use insulin. The increasing prevalence of diabetes highlights the need for consistent education among healthcare providers to aid patients in managing their conditions effectively.
To address the evolving nature of diabetes management and technology, ADEA has recently introduced micro-credentials for healthcare professionals, enhancing their understanding of diabetes care. Consistent messaging from various healthcare providers is vital, as conflicting information can lead to patient confusion and disengagement from care.
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
Source: Rewritten from transcript
-
Investigating use of dietary supplements for osteoarthritis
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
-
Startup Advances Biosensing
Melbourne based Nutromics is looking to solve some of the biggest healthcare challenges, by delivering on a mission to revolutionise precision medicine with Continuous Molecular Monitoring (CMM). Nutromics is developing biosensor technology integrated into a small and unobtrusive wearable smart patch.The software solution aims to be flexible and designed to connect with mobile and web solutions for integration with consumer health software and hospital platforms.
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
